We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
- Authors
Eriksson, B I; Dahl, O E; Rosencher, N; Kurth, A A; van Dijk, C N; Frostick, S P; Kälebo, P; Christiansen, A V; Hantel, S; Hettiarachchi, R; Schnee, J; Büller, H R; RE-MODEL Study Group
- Abstract
Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin inhibitor, that do not require monitoring or dose adjustment offer potential for prophylaxis against venous thromboembolism (VTE) after total knee replacement surgery.
- Publication
Journal of thrombosis and haemostasis : JTH, 2007, Vol 5, Issue 11, p2178
- ISSN
1538-7933
- Publication type
Journal Article
- DOI
10.1111/j.1538-7836.2007.02748.x